Revenue Milestone Payments. (1) Thirty Million United States Dollars ($30,000,000) payable to Seller if and when the Net Sales of the Cardene [****]* Product in any twelve consecutive month period, calculated as of the end of each calendar month, first exceed Eighty Million United States Dollars ($80,000,000).
Appears in 3 contracts
Samples: Asset Purchase Agreement (PDL Biopharma, Inc.), Asset Purchase Agreement (Biotech Spinco, Inc.), Asset Purchase Agreement (Facet Biotech Corp)
Revenue Milestone Payments. (1) Thirty Million United States Dollars ($30,000,000) payable to Seller if and when the Net Sales of the Cardene [****]* PMB Product in any twelve consecutive month period, calculated as of the end of each calendar month, first exceed Eighty Million United States Dollars ($80,000,000).
Appears in 1 contract